Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.76 USD 1.47% Market Closed
Market Cap: 815.2m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Total Liabilities
$335.8m
CAGR 3-Years
24%
CAGR 5-Years
102%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Total Liabilities
CA$8.1m
CAGR 3-Years
2%
CAGR 5-Years
20%
CAGR 10-Years
33%
Replicel Life Sciences Inc
XTSX:RP
Total Liabilities
CA$7m
CAGR 3-Years
10%
CAGR 5-Years
29%
CAGR 10-Years
26%
Innovotech Inc
XTSX:IOT
Total Liabilities
CA$381.6k
CAGR 3-Years
49%
CAGR 5-Years
18%
CAGR 10-Years
-11%
No Stocks Found

Abcellera Biologics Inc
Glance View

Market Cap
802.7m USD
Industry
Life Sciences Tools & Services

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. The company is headquartered in Vancouver, British Columbia and currently employs 386 full-time employees. The company went IPO on 2020-12-11. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

ABCL Intrinsic Value
1.67 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is Abcellera Biologics Inc's Total Liabilities?
Total Liabilities
335.8m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Total Liabilities amounts to 335.8m USD.

What is Abcellera Biologics Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
102%

Over the last year, the Total Liabilities growth was 9%. The average annual Total Liabilities growth rates for Abcellera Biologics Inc have been 24% over the past three years , 102% over the past five years .

Back to Top